ArticleProbiotics and antimicrobial proteins2026
Antagonistic Mechanisms of Probiotic Aliivibrio sp. Strain Vl2 Against Moritella viscosa: Evidence from Co-cultivation and Targeted Transcriptomic Analysis.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Invisible Balance: How Prebiotics and Probiotics Can Support Fish Health and Development.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Winter ulcers, primarily caused by Moritella viscosa, represent a significant challenge for the Norwegian aquaculture industry. Effective control measures are hampered by the lack of effective vaccines and limited use of antibiotics, driven by the global effort to combat antibiotic resistance. Recent studies have shown that probiotic Aliivibrio spp. colonize the skin and ulcers of Atlantic salmon and are linked to a reduced prevalence of winter ulcers. These observations suggest that M. viscosa and Aliivibrio spp. may interact within ulcers in vivo. In this study, we investigated how the probiotic Aliivibrio sp. strain Vl2 (hereafter Aliivibrio Vl2) modulates M. viscosa in vitro, using both co-cultures and cultures within the salmonid cell line CHSE-214. We found that this probiotic strain antagonizes M. viscosa, reducing its growth and its pathogenicity toward the salmonid cells. Targeted transcriptome analysis of Aliivibrio Vl2 during co-culture revealed potential antagonistic mechanisms that impede the growth of this competing pathogen. Together, our findings demonstrate that this probiotic bacterium inhibits M. viscosa growth in vitro. Furthermore, the identified transcriptomic changes suggest potential mechanisms underlying the reduced prevalence of winter ulcers observed in field studies after probiotic administration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.